Slide 1: Results
RESULTS NASDAQ GLOBAL MARKET: CCLD, CCLDO A healthcare technology company with 25 years of experience, delivering AI-driven, end-to-end solutions that power real-world clinical and financial transformation. © CareCloud, Inc. 2025
Slide 2: © CareCl oud, Inc. 2025
This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such
Slide 3: Presenters
Mahmud Haq Stephen Snyder A. Hadi Chaudhry Norman Roth Founder & Co-Chief Executive Officer Co-Chief Executive Officer CFO & Corporate Controller Executive Chairman © CareCl oud,Inc. 2025 2
Slide 4: Co-Chief Executive Officer
Co-Chief Executive Officer © CareCloud, Inc. 2025 3
Slide 5: Resilient Y-o-Y Revenue Growth and Net Income Turnaround
Resilient Y-o-Y Revenue Growth ($ mm) Net Income Turnaround ($ mm) 6.2% 1.95 27.6 26.0 (0.24) Q1’24 Q1’25 Q1’24 Q1’25 © CareCl oud,Inc. 2025 4
Slide 6: Free Cash Flow & Preferred Dividend; Capital Structure
Free Cash Flow & Preferred Dividend Capital Structure – Pre Conversion Capital Structure – Post (mm)* Conversion** -61.5% +63.6% 3.9 3.6 31% 2.2 38% 1.5 62% 69% Q1’24 Q1’25 Free Cash Flow Common Equity Common Equity Preferred Dividend Preferred Equity Preferred Equity *Series A preferred dividend sh
Slide 7: M&A 20+ Acquisitions
Early 2025 Transactions Why M&A Remains Core to Our Model 1 M&A MesaBilling LLC Traditional Medical Billing Company 20+ Acquisitions Enhances Client Expected to be Base and RCM Accretive within 90 scale days Attractive Revenue is Closed Feb 2025 Customer Virtually all 2 Acquisition Cost Recurring Re
Slide 8: Co-Chief Executive Officer
Co-Chief Executive Officer © CareCloud, Inc. 2025 7
Slide 9: Why AI, Our Bold Response
Why AI Our Bold Response Strategic Imperatives Market Competitiveness: AI is transforming healthcare - innovation is key to leading the shift. Revenue Expansion: AI unlocks scalable, cost-efficient solutions for broader market reach. AI Center of Excellence Target Investment Margin Improvement: Laun
Slide 10: cirrusAI and Specialty EHR Portfolio
cirrusAI – our next-gen, end-to-end AI solution Expanding Specialty EHR Portfolio with Early transforming healthcare from check-in to follow-up Success in GI & Dermatology New Specialty focused cirrusAI Notes: EHRs Automates clinical note-taking using ambient intelligence We’re building AI-optimized
Slide 11: CFO & Corporate Controller
CFO & Corporate Controller © CareCloud, Inc. 2025 10
Slide 12: Revenue and Net (loss) income
Revenue ($ mm) Net (loss) income ($ mm) $27.6 $1.95 +6.2% $26.0 $(0.24) Q1’24 Q1’25 Q1’24 Q1’25 © CareCl oud,Inc. 2025 11
Slide 13: Adjusted EBITDA, Free Cash Flow and Adjusted Net Income
Adjusted EBITDA ($ mm)* Free Cash Flow ($ mm)* Adjusted net income ($ mm)* $5.6 51.4% $3.7 $3.6 +63.6% $2.2 $2.3 +941% $0.2 Q1’24 Q1’25 Q1’24 Q1’25 Q1’24 Q1’25 *See reconciliation of the Non-GAAP results in appendix © CareCl oud,Inc. 2025 12
Slide 14: FY 2025 Guidance
Revenue ($ mm) Adjusted EBITDA ($ mm)* Net Income per Share $114.0 $0.13 $28.0 +2.9% $110.8 $0.10 $(0.28) 13.9% $24.1 111.0 26.0 FY 2024 FY 2025 FY 2024 FY 2025 FY 2024 FY 2025 Actual Upper end Actual Upper end Actual Upper end Lower end Lower end Lower end *See reconciliation of the Non-GAAP result
Slide 15: Founder & Executive Chairman
Founder & Executive Chairman © CareCloud, Inc. 2025 14
Slide 16: Thank You!
Thank You! carecloud.com Investor Relations ir.carecloud.com Stephen Snyder ir@carecloud.com © CareCloud, Inc. 2025 15
Slide 17: © CareCloud, Inc. 2025
© CareCloud, Inc. 2025 16
Slide 18: Adjusted EBITDA to GAAP net (loss) income
(000s) Adjusted EBITDA to GAAP net (loss) income FY 2023 FY 2024 Q1 2024 Q1 2025 GAAP net (loss) income ($48,674) $7,851 ($241) $1,948 (Benefit) provision for income taxes (364) 160 39 41 Net interest expense 1,040 812 338 16 Foreign exchange / other expense 918 335 (5) 19 Stock-based compensation e
Slide 19: Adjusted net income to GAAP net (loss) income
(000s) Adjusted net income to GAAP net (loss) income` FY 2023 FY 2024 Q1 2024 Q1 2025 GAAP net (loss) income ($48,674) $7,851 ($241) $1,948 Foreign exchange / other expense 918 335 (5) 19 Stock-based compensation expense (benefit) 4,716 115 (708) 108 Amortization of purchased intangible assets 4,975